Identification of HTLV-I Tax Trans-activator Mutants Exhibiting Novel Transcriptional Phenotypes
Overview
Authors
Affiliations
The type I human T-cell leukemia virus (HTLV-I) encodes a 40-kD nuclear trans-regulatory protein termed Tax that transcriptionally activates the HTLV-I long terminal repeat (LTR), as well as select [corrected] cellular and heterologous viral promoters. Tax does not bind DNA specifically but, rather, acts in a more indirect manner. Tax activation of the HTLV-I LTR is mediated through constitutively expressed cellular factors that bind to cAMP response elements (CREs) present within the 21-bp enhancers of the LTR. In contrast, Tax transactivation of the interleukin-2 receptor-alpha gene (IL-2R alpha) and LTR of the type 1 human immunodeficiency virus (HIV-1) involves the induced nuclear expression of NF-kappa B. We now report the identification of missense mutations within the tax gene that functionally segregate these two pathways of trans-activation. Additionally, we demonstrate that the carboxyl terminus of the Tax protein, despite its acidic and predicted alpha-helical structure, is completely dispensable for trans-activation through either of these transcription factor pathways. Finally, we demonstrate that mutations within a putative zinc finger domain disrupt the nuclear localization of Tax and abolish trans-activation. These results demonstrate that Tax trans-activation of viral and cellular promoters involves at least two mechanisms of host transcription factor activation and suggest that this activation is likely mediated through distinct functional domains.
A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1.
Heym S, Krebs P, Ott K, Donhauser N, Kemeter L, Simon F Pathogens. 2024; 13(11).
PMID: 39599568 PMC: 11597676. DOI: 10.3390/pathogens13111015.
The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7.
Bellon M, Yeh C, Bai X, Nicot C J Virol. 2024; 98(7):e0040524.
PMID: 38874362 PMC: 11264933. DOI: 10.1128/jvi.00405-24.
HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis.
Zhao T, Wang Z, Fang J, Cheng W, Zhang Y, Huang J Proc Natl Acad Sci U S A. 2022; 119(9).
PMID: 35210364 PMC: 8892356. DOI: 10.1073/pnas.2115316119.
Heym S, Mohr C, Engelbrecht H, Fleckenstein B, Thoma-Kress A Cancers (Basel). 2022; 14(3).
PMID: 35158803 PMC: 8833421. DOI: 10.3390/cancers14030537.
Kohrt S, Strobel S, Mann M, Sticht H, Fleckenstein B, Thoma-Kress A Int J Mol Sci. 2021; 22(24).
PMID: 34948391 PMC: 8705299. DOI: 10.3390/ijms222413597.